![]()
|
|
||||||||
(Received for publication, April 3, 1996, and in revised form, June 14, 1996)
,
,
''
From the
Max-Planck-Institut für Biochemie, Am
Klopferspitz 18a, D-82152 Martinsried, Germany, the
§ Institut für Klinische Molekularbiologie und
Tumorgenetik, GSF-Forschungszentrum für Umwelt und Gesundheit,
Marchionistrasse 25, D-81377 München, Germany, and
¶ Abteilung für Molekulare Pathologie, Dermatologische
Klinik und Poliklinik der Universität München,
Frauenlobstrasse 9-11, D-80337 München, Germany
Vascular endothelial growth factor (VEGF), also known as vascular permeability factor, is strongly expressed by epidermal keratinocytes during wound healing, in psoriasis, and in bullous diseases such as erythema multiforme and bullous pemphigoid. All of these disorders are characterized by increased microvascular permeability and angiogenesis. Since the development of erythema as a result of hyperpermeable blood vessels is also a common feature after excess sun exposure, we speculated about an up-regulation of VEGF expression by ultraviolet (UV) light. To test this hypothesis, we analyzed the effect of UVB irradiation on VEGF expression in cultured keratinocytes. Thereby we found a large increase in VEGF mRNA and protein levels upon irradiation of quiescent keratinocytes with sublethal and physiologically relevant doses of UVB. Although H2O2 was also a potent inducer of VEGF expression, the effect of UVB irradiation is unlikely to be mediated by reactive oxygen species as determined by the use of antioxidants. Further experiments revealed that the UVB-induced overexpression of VEGF is dependent on de novo protein synthesis and might occur via release of soluble mediators, which subsequently turn on VEGF expression. In summary, our results suggest a novel role of VEGF in the induction of erythema after excess sun exposure.
Vascular endothelial growth factor (VEGF),1 also known as vascular permeability factor and vasculotropin, is a potent, multifunctional cytokine that exerts several important actions on vascular endothelium (for review, see Ref. 1). VEGF was originally discovered as a tumor-secreted protein that rendered venules and small veins hyperpermeable to circulating macromolecules (2). Subsequent purification and molecular cloning revealed VEGF to be a 34-42-kDa homodimeric, heparin-binding glycoprotein that is secreted by various cell types including keratinocytes (3, 4, 5, 6, 7, 8, 9, 10, 11). Four different VEGF isoforms have been identified which arise from alternative splicing of a single transcript (12, 13). The two larger variants, VEGF189 and VEGF206, remain cell-associated whereas the two smaller forms, VEGF121 and VEGF165, are secreted (13, 14). Two transmembrane type III tyrosine kinases, KDR (15, 16, 17) and flt-1 (18), have been identified as high affinity VEGF receptors. They are expressed predominantly, if not exclusively, by vascular endothelial cells. Overexpression of VEGF and both of its receptors has been documented in a number of animal and human tumors (for review, see Refs. 1 and 19), and VEGF is thought to play an important role in the increased vascular permeability and angiogenesis associated with these malignancies. VEGF is also overexpressed by epidermal keratinocytes in certain non-neoplastic processes of the skin which are characterized by increased microvascular permeability and angiogenesis, e.g. cutaneous wound healing (9) and psoriasis (20). Recently, up-regulation of VEGF was also found in bullous pemphigoid, erythema multiforme, and dermatitis herpetiformis (21), which are all associated with hyperpermeable dermal microvessels.
These findings led us to hypothesize that increased expression of VEGF
might also play an important role in the development of
sunlight-induced erythema. Exposure to solar ultraviolet B (UVB)
radiation is known to induce multiple inflammatory and carcinogenous
reactions in the skin (for review, see Ref. 22). Upon UVB irradiation,
keratinocytes express several proinflammatory cytokines, including
tumor necrosis factor
and interleukin 1
and
(IL-1
and
IL-1
) (23, 24, 25), which promote reactions of other effector cells in
the skin, e.g. leukocytes and endothelial cells. Here we
show that low dose UVB irradiation leads to a strong increase in VEGF
mRNA and protein levels in human keratinocytes in vitro.
Since this increase is not inhibited by antioxidants, reactive oxygen
species are unlikely to be involved in the UVB-dependent
up-regulation of VEGF. Experiments with cycloheximide and with
conditioned medium from UVB-treated cells suggest that the induction of
VEGF expression by UVB is indirect and depends on the release of
soluble factors that subsequently turn on VEGF expression.
The human keratinocyte cell line HaCaT (26) was maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, penicillin (100 units/ml) and streptomycin (100 µg/ml). For experiments with H2O2, keratinocytes were grown in RPMI 1640 medium supplemented with the same components as above. This medium does not contain iron salts, which are known to promote the decomposition of H2O2. In both cases, cells were grown to confluence without changing the medium and rendered quiescent by a 16-h incubation in serum-free medium. Cells were then incubated for varying periods in serum-free medium containing H2O2, pyrrolidine dithiocarbamate (PDTC), cycloheximide, or conditioned medium from UVB-treated cells. Dulbecco's modified Eagle's medium, RPMI 1640, and fetal bovine serum were purchased from Life Technologies, Inc. PDTC, cycloheximide, and H2O2 were from Sigma.
UVB Irradiation of CellsFor UVB treatment, confluent and quiescent cells were washed twice with phosphate-buffered saline, irradiated while under a thin film of phosphate-buffered saline, and replenished with their own medium thereafter. The UVB source was a parallel bank of three TL20/12 fluorescent tubes (Philips, Hamburg) emitting a continuous spectrum between 280 and 320 nm with a peak emission at 312 nm. Fluence rate at the site of cell irradiation was 0.86 milliwatts/cm2 as measured with a Centra radiometer (Osram, Munich). The UVB doses employed ranged from 5 to 20 mJ/cm2 (exposure time: 7-26 s) and were sublethal for the cells (data not shown). These doses are a realistic representation of the irradiation reaching basal keratinocytes in vivo (27). Aliquots of cells were harvested before and at different time points after UVB irradiation and used for RNA isolation.
RNA Isolation and RNase Protection AssayRNA isolation was
performed as described (28). RNase protection assays were carried out
as published recently (29). Briefly, a 159-base pair fragment
corresponding to nucleotides 339-498 of the human VEGF121
cDNA (30) was cloned into the transcription vector pBluescript
KSII(+) (Stratagene) and linearized at the 5
-end. An antisense
transcript was synthesized in vitro using T3 RNA polymerase
and [32P]UTP (800 Ci/mmol, Amersham). 20 µg of total
cellular RNA was hybridized at 42 °C overnight with 100,000 cpm of
the labeled antisense transcript. Hybrids were digested with RNases A
and T1 for 1 h at 30 °C. Protected fragments were separated on
5% acrylamide, 8 M urea gels and analyzed by
autoradiography. The increase in VEGF mRNA levels was quantitated
by PhosphorImager analysis (FUJI BAS 1000, Fuji).
5 ml of serum-free Dulbecco's modified Eagle's medium/10-cm Petri dish was conditioned by UVB-irradiated quiescent HaCaT cells. 8 and 24 h after irradiation the conditioned medium from three Petri dishes was harvested and centrifuged to remove cell debris. Heparin-binding proteins were precipitated from the supernatant with 100 µl of heparin-Sepharose (1:1 slurry; Pharmacia) overnight at 4 °C. Heparin-Sepharose beads were precipitated by centrifugation and washed three times with 20 mM Tris-HCl, pH 7.4, 300 mM NaCl. Heparin-Sepharose-bound proteins were extracted by a 5-min incubation in Laemmli sample buffer at 95 °C and separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. After transfer to nitrocellulose membranes, VEGF proteins were detected using a polyclonal antiserum directed against the amino terminus of VEGF (Santa Cruz Biotechnology) and an alkaline phosphatase detection system (Promega). Conditioned medium from nontreated cells was used as a negative control, whereas a cell lysate from COS cells transiently transfected with a VEGF cDNA was used as a positive control.
To investigate the role of
sunlight on VEGF expression in the skin, we studied the effect of UVB
on VEGF expression in the human keratinocyte cell line HaCaT. For this
purpose, cells were irradiated with physiologically relevant doses of
UVB and harvested at different time points after UVB treatment. As
shown in Fig. 1A, low levels of VEGF mRNA
were detected in quiescent, nontreated keratinocytes. Within 5 h
after UVB irradiation (10 and 20 mJ/cm2), a large induction
of VEGF mRNA expression was observed with highest levels 8 h
after exposure to 20 mJ of UVB/cm2 (Fig. 1,
A and B). At this time point, VEGF mRNA
levels were 11-fold higher compared with the basal level. This effect
was long lasting, and 24 h after exposure of the cells to UVB,
VEGF mRNA levels were still elevated (2-3-fold).
-end of human
VEGF121 was used to detect VEGF transcripts. A 159-base
pair protected fragment corresponding to the complete hybridization
probe is expected for transcripts encoding VEGF121. Two
shorter protected fragments of 86 and 73 base pairs are generated by
mRNA encoding larger forms of VEGF. The fragments that are
protected by the different forms of VEGF are indicated as solid
bars below the RNAs.
Four different VEGF proteins have recently been identified in
vitro which arise from differential splicing at the 3
-end of VEGF
primary transcripts (12, 13). The hybridization probe that we used for
RNase protection assays corresponds to the 3
-end of the shortest form
of VEGF (VEGF121) and thus enabled us to distinguish among
the different isoforms of this growth factor (Fig. 1C). A
protected fragment corresponding to the complete coding sequence of the
hybridization probe is generated by mRNA encoding
VEGF121 (upper band in Fig. 1A),
whereas two shorter protected fragments are generated by mRNAs
encoding longer variants of VEGF (lower bands in Fig.
1A). mRNAs encoding VEGF121 and other splice
variants were induced to a similar extent (Fig. 1A).
To analyze whether the observed increase in VEGF mRNA levels
correlates with the production of immunoreactive VEGF protein,
conditioned medium from UVB-irradiated and nonirradiated HaCaT cells
was analyzed for the presence of VEGF protein. Because of the kinetics
of the VEGF induction at the mRNA level, conditioned medium was
harvested 8 and 24 h after irradiation, and VEGF protein was
enriched by its capacity to bind to heparin-Sepharose. The presence of
VEGF protein in the conditioned medium was detected by immunoblotting
using a polyclonal antiserum directed against the amino terminus of
VEGF, which is identical in all isoforms. As shown in Fig.
2, two VEGF proteins with estimated molecular masses of
17 and 19 kDa were detected in the conditioned medium of UVB-treated
cells. The size of these proteins correlates with the expected sizes of
the VEGF gene products. A VEGF specific band of about 36 kDa might
represent a dimer of VEGF. The highest levels of VEGF protein were
found 24 h after irradiation, whereas no VEGF protein was
detectable in conditioned medium of nonirradiated cells. As a positive
control, we used lysates from COS cells transiently transfected with a
VEGF cDNA. As shown in the right lane of Fig. 2, a VEGF
specific protein of about 22 kDa was detected in these cells which was
not seen in vector-transfected control cells. Taken together these data
demonstrate that the increase in VEGF mRNA after UVB irradiation
correlates with accumulation of immunoreactive VEGF protein in the
medium.
Induction of VEGF Expression by UVB Is Not Mediated by Oxygen Radicals
UV irradiation of cells has been shown to increase the
intracellular levels of reactive oxygen species (31). To determine if
this effect was responsible for the increase in VEGF expression after
UVB exposure, we first analyzed the effect of
H2O2 on VEGF mRNA expression in HaCaT
cells. As shown in Fig. 3A, treatment of the
cells with 1 mM H2O2 caused a
strong increase in VEGF mRNA expression. As expected, pretreatment
of the cells with the antioxidant PDTC (20 µM) completely
abolished the effect of H2O2, whereas PDTC
itself did not influence VEGF expression (Fig. 3B). By
contrast, no inhibition of the UVB-dependent increase in
VEGF mRNA was observed in PDTC-pretreated cells (Fig.
3C). Thus, although H2O2 is a potent
inducer of VEGF expression, reactive oxygen species are unlikely to be
responsible for VEGF up-regulation by UVB.
Up-regulation of VEGF Expression after UVB Irradiation Is Dependent on de Novo Protein Synthesis
Recent studies from our laboratory
have demonstrated the rapid induction of VEGF expression in HaCaT cells
by various growth factors within 10-30 min (32). This increase is
independent of de novo protein synthesis. By contrast,
up-regulation of this gene by UVB occurred only 5-8 h after
irradiation, suggesting that de novo protein synthesis might
be required for this effect. Therefore, we investigated the effect of
the protein synthesis inhibitor cycloheximide on the UVB- and
H2O2-induced VEGF expression. As seen with most
primary response genes, treatment of quiescent HaCaT cells with this
reagent already caused increased VEGF expression (Fig.
4A), and a strong superinduction was seen
after addition of both cycloheximide and H2O2
(Fig. 4B). These findings suggest a direct effect of
H2O2 on VEGF expression. In contrast, no
superinduction was observed after UVB irradiation of
cycloheximide-treated cells. Moreover, the cycloheximide-induced VEGF
up-regulation was even reduced by UVB (Fig. 4A). Thus, the
effect of UVB is most likely to be indirect. To test this hypothesis
further, we analyzed the potency of conditioned medium of UVB-treated
cells to induce VEGF expression in quiescent HaCaT cells. As shown in
Fig. 5A, medium conditioned for 8 or 24 h by UVB-irradiated cells strongly induced VEGF expression. This
induction was comparable to the increase seen after the addition of
10% fetal bovine serum. By contrast, conditioned medium from
nonirradiated cells had no effect on VEGF expression. This result
suggests that UVB irradiation causes release of soluble mediators that
subsequently turn on VEGF expression.
Solar radiation causes a variety of biological effects in the skin. Whereas low doses of UV radiation can be useful due to the photosynthesis of vitamin D, larger doses cause sunburn and, when exposure is chronic, can promote tumor formation. Sunburn is characterized by erythema and edema as a result of increased vascular permeability. The mechanisms that underlie these effects have not been elucidated fully. Since erythema is particularly induced by UVB irradiation that only penetrates into the epidermis (33), keratinocyte-derived soluble mediators that diffuse to the dermis are likely to mediate this effect. This diffusion theory is supported by the lag phase between UVB exposure and the appearance of visible erythema and by the increase in the latent period for visible erythema after cooling of the skin (34). The soluble mediators that induce increased vascular permeability have only partially been characterized. Previous studies have suggested an important role of prostaglandins in this process. However, the later stages of erythema cannot be explained fully by the presence of these factors (for review, see Ref. 33). Therefore, additional mediators might contribute to the effect.
One of the most potent vascular permeability factors is VEGF, which is overexpressed in a wide variety of physiological and pathological conditions associated with increased vascular permeability, such as cancer and wound healing and also in erythema seen in several blistering diseases (1, 9, 21). The results described in the present study suggest an additional role of VEGF in UVB-induced erythema. UVB irradiation of cultured keratinocytes resulted in a strong increase in VEGF mRNA and protein levels. These elevated levels might either be due to transcriptional activation of the VEGF gene and/or to increased mRNA stability since both mechanisms have been shown to contribute to the regulation of VEGF mRNA levels (35).
The UVB dose and spectrum used in this study were well comparable to the UVB light reaching the human skin upon sun exposure, suggesting that a similar increase in VEGF expression might occur in vivo. Thus, in addition to prostaglandins, VEGF might contribute further to the induction of erythema by UVB irradiation. This hypothesis is supported by a recent study that demonstrated a synergistic effect of prostaglandin E2 and VEGF in a quantitative model of local plasma leakage in rabbit skin (36), and a similar synergistic effect might occur in human skin after sun exposure.
The effects of UV irradiation are frequently mediated by reactive oxygen species, and increased levels of hydrogen peroxide, hydroxyl radicals, superoxide, and organic hydroperoxides are found in many different cell types following UV exposure (31, 33). These reactive oxygen species are potent modulators of transcription factor activity (37, 38), resulting in significant changes in gene expression. Therefore we speculated about a role of these molecules in the induction of VEGF expression seen after UVB exposure. Indeed, treatment of keratinocytes with H2O2 caused a strong increase in VEGF expression which was blocked by antioxidants. By contrast, antioxidants had no effect on the UVB-induced VEGF expression, suggesting that UVB irradiation and H2O2 induce expression of this gene via different mechanisms. The induction of VEGF expression by UVB in the presence of antioxidants is in agreement with recent results that demonstrated the involvement of reactive oxygen intermediates in the UVA but not in the UVB response (39).
A series of previous studies suggested an important role of tyrosine phosphorylation but not of protein kinase C activation in the induction of gene expression by UVC and UVB (40, 41, 42, 43, 44), and preliminary studies of our laboratory suggest that similar mechanisms might be responsible for the increased expression of VEGF after UVB irradiation. Thus, pretreatment of the cells with protein tyrosine kinase inhibitors blocked the UVB response, whereas protein kinase C inhibitors had no effect.
Interestingly, induction of VEGF expression in keratinocytes by
H2O2 and various growth factors and cytokines
occurred much more rapidly compared with the induction seen after UVB
exposure (32 and data not shown). This finding suggested that indirect
mechanisms might be responsible for the UV effect. This hypothesis was
supported by the results seen with cycloheximide. Whereas a combination
of H2O2 and the protein synthesis inhibitor
caused a strong superinduction of VEGF expression, induction of this
gene by UVB was reduced slightly in the presence of cycloheximide. The
indirect nature of the UVB effect was proven further by the induction
of VEGF expression by conditioned medium from UVB-treated
keratinocytes. This finding demonstrates that UVB irradiation of these
cells causes release of soluble factors that subsequently turn on VEGF
expression. Proinflammatory cytokines are the most likely candidates
for this effect. Thus, expression of IL-1
, IL-1
, and tumor
necrosis factor
have been shown to be induced in keratinocytes by
UVB irradiation (23, 24, 25), and expression of these cytokines precedes
the increased expression of VEGF in these cells (data not shown). Since
IL-1 and tumor necrosis factor
are potent inducers of VEGF
expression in HaCaT cells (32), a combined action of these factors
might be responsible for induction of VEGF expression by UVB. A similar
cytokine-mediated effect has recently been demonstrated for the
UVB-induced prostaglandin E2 expression in keratinocytes
(45), suggesting that various UV effects could be mediated by these
factors.
In summary, our data demonstrate a strong induction of VEGF expression by UVB which is mediated by the release of soluble factors. These findings suggest a novel and important role of VEGF in the induction of erythema after prolonged sun exposure. Future studies using animal models will help to clarify further the role of this multipotent factor in the UVB response in vivo.
Present address: Fred Hutchinson Cancer Research Center, 1124 Columbia St., Seattle, WA 98104.
We thank Dr. Peter Hans Hofschneider for helpful suggestions and support, Frédérique Torterotot for excellent technical assistance, and Dr. H. Weich for the human VEGF cDNA.
This article has been cited by other articles:
![]() |
N. Di Girolamo, D. Wakefield, and M. T. Coroneo UVB-Mediated Induction of Cytokines and Growth Factors in Pterygium Epithelial Cells Involves Cell Surface Receptors and Intracellular Signaling. Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2430 - 2437. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Premanand, M. Rema, M. Z. Sameer, M. Sujatha, and M. Balasubramanyam Effect of Curcumin on Proliferation of Human Retinal Endothelial Cells under In Vitro Conditions Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 2179 - 2184. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Connor, S. Subbaram, K. J. Regan, K. K. Nelson, J. E. Mazurkiewicz, P. J. Bartholomew, A. E. Aplin, Y.-T. Tai, J. Aguirre-Ghiso, S. C. Flores, et al. Mitochondrial H2O2 Regulates the Angiogenic Phenotype via PTEN Oxidation J. Biol. Chem., April 29, 2005; 280(17): 16916 - 16924. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hirakawa, S. Fujii, K. Kajiya, K. Yano, and M. Detmar Vascular endothelial growth factor promotes sensitivity to ultraviolet B-induced cutaneous photodamage Blood, March 15, 2005; 105(6): 2392 - 2399. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Podar and K. C. Anderson The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications Blood, February 15, 2005; 105(4): 1383 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Wheeler, O. M. Smutney, and R. J. Samulski Secretion of Extracellular Superoxide Dismutase From Muscle Transduced With Recombinant Adenovirus Inhibits the Growth of B16 Melanomas in Mice Mol. Cancer Res., October 1, 2003; 1(12): 871 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Shatrov, V. V. Sumbayev, J. Zhou, and B. Brune Oxidized low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1{alpha} (HIF-1{alpha}) accumulation via redox-dependent mechanisms Blood, June 15, 2003; 101(12): 4847 - 4849. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Chung, K. Yano, M. K. Lee, C. S. Youn, J. Y. Seo, K. H. Kim, K. H. Cho, H. C. Eun, and M. Detmar Differential Effects of Photoaging vs Intrinsic Aging on the Vascularization of Human Skin Arch Dermatol, November 1, 2002; 138(11): 1437 - 1442. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. A. Duyndam, T. M. Hulscher, D. Fontijn, H. M. Pinedo, and E. Boven Induction of Vascular Endothelial Growth Factor Expression and Hypoxia-inducible Factor 1alpha Protein by the Oxidative Stressor Arsenite J. Biol. Chem., December 14, 2001; 276(51): 48066 - 48076. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cho, T. K. Hunt, and M. Z. Hussain Hydrogen peroxide stimulates macrophage vascular endothelial growth factor release Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2357 - H2363. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kosmidou, A. Xagorari, C. Roussos, and A. Papapetropoulos Reactive oxygen species stimulate VEGF production from C2C12 skeletal myotubes through a PI3K/Akt pathway Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L585 - L592. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Berking, R. Takemoto, K. Satyamoorthy, R. Elenitsas, and M. Herlyn Basic Fibroblast Growth Factor and Ultraviolet B Transform Melanocytes in Human Skin Am. J. Pathol., March 1, 2001; 158(3): 943 - 953. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Sheikh, J. J. Gibson, M. D. Rollins, H. W. Hopf, Z. Hussain, and T. K. Hunt Effect of Hyperoxia on Vascular Endothelial Growth Factor Levels in a Wound Model Arch Surg, November 1, 2000; 135(11): 1293 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lu, T. Kasama, K. Kobayashi, Y. Yoda, F. Shiozawa, M. Hanyuda, M. Negishi, H. Ide, and M. Adachi Vascular Endothelial Growth Factor Expression and Regulation of Murine Collagen-Induced Arthritis J. Immunol., June 1, 2000; 164(11): 5922 - 5927. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. V. Diaz, M.-C. Lenoir, A. Ladoux, C. Frelin, M. Demarchez, and S. Michel Regulation of Vascular Endothelial Growth Factor Expression in Human Keratinocytes by Retinoids J. Biol. Chem., January 7, 2000; 275(1): 642 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak Vascular endothelial growth factor (VEGF) and its receptors FASEB J, January 1, 1999; 13(1): 9 - 22. [Abstract] [Full Text] |
||||
![]() |
T. Suhara, K. Fukuo, T. Sugimoto, S. Morimoto, T. Nakahashi, S. Hata, M. Shimizu, and T. Ogihara Hydrogen Peroxide Induces Up-Regulation of Fas in Human Endothelial Cells J. Immunol., April 15, 1998; 160(8): 4042 - 4047. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |